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Gut microbiota has been shown to have an important influence on host health.
The microbial composition of the human gut microbiota is modulated by diet and
other lifestyle habits and it has been reported that microbial diversity is altered in
obese people. Obesity is a worldwide health problem that negatively impacts the
quality of life. Currently, the widespread treatment for obesity is bariatric surgery.
Interestingly, gut microbiota has been shown to be a relevant factor in effective
weight loss after bariatric surgery. Since that the human gut microbiota of normal
subjects differs between geographic regions, it is possible that rearrangements of
the gut microbiota in dysbiosis context are also region-specific. To better understand
how gut microbiota contribute to obesity, this study compared the composition of
the human gut microbiota of obese and lean people from six different regions and
showed that the microbiota compositions in the context of obesity were specific to
each studied geographic location. Furthermore, we analyzed the functional patterns
using shotgun DNA metagenomic sequencing and compared the results with other
obesity-related metagenomic studies, we observed that microbial contribution to
functional pathways were country-specific. Nevertheless, our study showed that
although microbial composition of obese patients was country-specific, the overall
metabolic functions appeared to be the same between countries, indicating that different
microbiota components contribute to similar metabolic outcomes to yield functional
redundancy. Furthermore, we studied the microbiota functional changes of obese
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patients after bariatric surgery, by shotgun metagenomics sequencing and observed
that changes in functional pathways were specific to the type of obesity treatment. In
all, our study provides new insights into the differences and similarities of obese gut
microbiota in relation to geographic location and obesity treatments.
Keywords: human gut microbiota, bariatric surgery, obesity, functional redundancy, metagenomic, functional
convergence
INTRODUCTION
It has been established that the composition of human gut
microbiota greatly influences human health (Carding et al.,
2015, reviewed by Hall et al., 2017). Although the microbiota
composition of each individual is relatively stable across adult
life, it varies widely between individuals (Lozupone et al., 2012;
Kolde et al., 2018). It has been observed that the human gut
microbiota is primarily dominated by the phyla Firmicutes and
Bacteroidetes (Zhernakova et al., 2016), with lesser contribution
from Actinobacteria, Proteobacteria and Verrucomicrobia (Qin
et al., 2010). Nevertheless, the microbiota composition differs
geographically, primarily based on a variety of factors including
host genetics, dietary habits, age, geographic location and lifestyle
(Yatsunenko et al., 2012; Chilton, 2014; Nishijima et al., 2016;
Fujio-Vejar et al., 2017; Gupta et al., 2017). To date, most of the
studies on human gut microbiota have focused on populations
from North America and Europe and although several of studies
have demonstrated associations between microbiota alterations
and diseases, including obesity, the specific contribution of these
alterations to treatment response and how they differ across
geographic locations still need to be envisioned.
Worldwide, obesity has nearly tripled since 1980 (Stevens
et al., 2012). Information published by the World Health
Organization (2016) shows that more than 1.9 billion adults,
18 years and older, have a body mass index (BMI) above 25 kg/m2
among which, over 650 million have a BMI > 30 kg/m2, hence
classifying them as obese. Overweight and obesity are defined
as abnormal or excessive fat accumulation due to environmental
and genetic factors (Angelakis et al., 2012). While overweight
individuals haves a BMI range between 25 and less than 30 kg/m2,
obesity is classified by BMI as: obesity grade 1 (30 to 35 kg/m2),
grade 2 (35 to 40 kg/m2) and grade 3 (40 to 60 kg/m2) (NHLBI
Expert Panel, 1998). Diverse studies have associated obesity with
altered gut microbiota and reduced functional potential (Ley
et al., 2006; Turnbaugh et al., 2006; Tremaroli and Backhed, 2012;
Karlsson et al., 2013; Le Chatelier et al., 2013; Damms-Machado
et al., 2015; Haro et al., 2016; Medina et al., 2017), which can be
partially reversed after surgical intervention (Palleja et al., 2016).
It has been originally observed that the relative abundance of
Firmicutes and Bacteroidetes can be altered in obese patients,
where an over-representation of Firmicutes is observed, in
contrast to their lean counterparts (Ley et al., 2006; Turnbaugh
et al., 2009; Million et al., 2012; Walters et al., 2014; Kasai et al.,
2015; Haro et al., 2016). These taxonomic differences between
lean and obese subjects may contribute to the development
and perpetuation of obesity in several ways, including fat
storage, regulation of energy metabolism, energy extraction from
short chain fatty acids, increased low-grade inflammation and
altered bile acid metabolism (Qin et al., 2012; Karlsson et al.,
2013; Khan et al., 2016). However, a recent study focusing
on the meta-analysis of previously published data using forest
machine learning models showed no significant differences in gut
microbiota composition between obese and healthy individuals
(Sze and Schloss, 2016). Nevertheless, further research is required
to unravel the exact role of gut microbiota composition in
obesity context, and the factors, including geographical location,
that may have an influence on not only differential microbial
abundance but also long-term patient outcome.
Gastric surgical procedures, commonly known as bariatric
surgery, have been successful in mediating long-term weight loss
and reducing the incidence of related comorbidities (Sjöström,
2008; Eldar et al., 2011). Roux-en-Y gastric bypass (RYGB) is
one of the most common bariatric surgery procedures in the
United States (Smoot et al., 2006), where a small stomach pouch
is connected to the proximal jejunum to directly bypass food
to the small intestine, resulting in restrictive and malabsorptive
nutrient intake (Tice et al., 2008; Tran et al., 2016). Another
common bariatric surgery is sleeve gastrectomy (SG), where a
significant portion of the stomach is removed to decrease its
volume, leading to a significant reduction in the amount of
food consumed (Gumbs et al., 2007). Since their invention, a
number of studies have observed changes in obesity-associated
microbiota and functional gene richness following different
types of bariatric surgery (Zhang et al., 2009; Graessler et al.,
2013; Kong et al., 2013; Tremaroli et al., 2015; Shao et al.,
2016; Ilhan et al., 2017; Medina et al., 2017; Murphy et al.,
2017). Specific changes following surgical intervention include an
increase in Proteobacteria (Escherichia coli, Enterobacter spp.),
changes in Bacteroides and Prevotella abundance, accompanied
by an increase in Akkermansia and a decline in Clostridium
genus, and global changes in Firmicutes/Bacteroidetes phyla
ratios (Zhang et al., 2009; Furet et al., 2010; Li et al., 2011;
Kong et al., 2013; Damms-Machado et al., 2015; Louis et al.,
2016; Palleja et al., 2016; Ilhan et al., 2017; Medina et al., 2017).
These microbial changes following bariatric surgery have shown
to mediate different outcomes and, interestingly, such changes
appear to depend on the type of surgery performed (Ilhan et al.,
2017; Medina et al., 2017; Murphy et al., 2017). Specifically,
metagenomic studies following RYGB showed an increase in
pathways involving aerobic respiration and glutathione transfer
and metabolism (Palleja et al., 2016). Both observations were
in agreement with the increase in Proteobacteria phylum
abundance, driven by facultative anaerobes, such as E. coli,
as a result of lower gastric acid exposure during stomach
transit. In the same study, the authors found an increase in
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the pathways that degrade putrescine to succinate to produce
gamma-aminobutyric acid (GABA) as a byproduct. GABA is
known to act on receptors in the hypothalamus to promote
satiety and, additionally, is thought to promote GLP-1 release, a
positive regulator of GABA production by pancreatic beta-cells,
which provides further involvement of this pathway following
RYGB (Palleja et al., 2016). In addition, a complementary study
conducted 9 years after RYGB intervention showed that bacterial
rearrangements were stable in the long run and surgically altered
microbiota promoted reduced fat deposition in recipient mice
(Tremaroli et al., 2015).
In this study, we compared the gut microbiota composition
and functional patterns of obese subjects from Chile with
published data from Italy, Denmark, United States, France,
and Saudi Arabia, in order to better understand the microbiota
contribution to obesity. We found obese subjects to show
geographic specificity in regards to relative microbiota
abundance, similar to what has been previously observed in
healthy individuals. Interestingly, the gut microbiota of obese
patients did not display differential enrichment of functional
pathways between countries, indicating that the geography-
specific microbial compositions converge to perform similar
functions in obese individuals. Furthermore, this study analyzed
the metagenomic profiles of Chilean patients subjected to gastric
bypass and sleeve gastrectomy and observed changes in the
functional capacity of gut microbiota after surgery. Specifically,
we identified Akkermansia muciniphila as one of the bacteria
that drives the change in metabolic pathways after surgical
intervention for obesity in Chilean patients.
MATERIALS AND METHODS
Sample and DNA Raw Data Collection
DNA raw data sequences from the stool of obese and lean
subjects were obtained from studies carried out in Chile (Medina
et al., 2017; Thomson et al., 2019), Italy (Tremaroli et al., 2015),
Denmark (Palleja et al., 2016), United States (Ilhan et al., 2017),
France and Saudi Arabia (Yasir et al., 2015), described in Table 1
and Supplementary Table S1. In addition, 12 DNA stool samples
from Chilean obese patients before and after treatment obtained
from a previous study (Medina et al., 2017) were sequenced
using shotgun metagenomics. All experiments were conducted in
accordance with the Declaration of Helsinki and approved by the
Ethics Committee of the Faculty of Medicine, Pontifical Catholic
University of Chile (n◦ 15-337).
Taxonomic Profiling From 16S rDNA
Gene Amplicon Sequencing
Raw data of DNA sequences belonging to different studies
were downloaded from ENA-EMBL or SRA-NCBI databases
(Supplementary Table S1). To access the microbiota taxa and
abundance, in this study we re-analyzed all raw data sequences
using Microbiome Helper v2.3 OVA pipeline (Comeau et al.,
2017). Briefly, MiSeq paired-end sequences were joined using
PEAR (Zhang et al., 2014). Joined sequences were filtered
by quality and length, in which demultiplexing and barcode
depletion were performed using Microbiome Helper and QIIME
v1.9.1 scripts (Caporaso et al., 2010; Navas-Molina et al., 2013;
Comeau et al., 2017). Chimera sequences were filtered using
the Vsearch tool (Rognes et al., 2016). Operational taxonomic
units (OTUs) were picked by open-reference command and
defined by clustering at 3% divergence (97% similarity) using
the GreenGenes database release 08-2013 as reference (DeSantis
et al., 2006; McDonald et al., 2012). Diversity analyses were
performed using QIIME v1.9.1 scripts under Microbiome
Helper v2.3 environment. The sequencing depth for even sub-
sampling and maximum rarefaction depth was at least 10000
counts/sample, regard the minimum value obtained after OTU-
picking for each data set (Supplementary Table S2). Predictive
metagenomic functional profiling of microbial composition were
performed using PICRUSt (Langille et al., 2013), following
the instructions provided in their Metagenomic Prediction
Tutorial. KEGG Orthology analyses were performed using
the “ko_to_pathway_map” PICRUSt database to identify the
enrichment of metabolic pathways.
Taxonomic abundance and metagenomic prediction tables
were exported to R environment (R Core Team, 2013) for
statistical analysis and figures were represented using the package
LSD Lots of Superior Depictions (Schwalb et al., 2011). Volcano
plots were constructed using the adjusted FDR p-value obtained
from the unpaired t-test comparisons and the fold change of each
condition. The taxonomic processed data obtained from QIIME
and the metadata for the raw data files used in this study are
exhibited in Supplementary Table S2.
The PICRUSt functional prediction was validated comparing
the KEGG Orthology abundances obtained with the Uniref90
metagenomic abundances from the HUMAnN2 output. For
this, the metagenomic Uniref90 table was converted to KEGG
Orthology using the script humann2_regroup_table from
HUMAnN2 (Abubucker et al., 2012). Both KEGG Orthology
datasets were merged by row and normalized using quantile
normalization to compare linear dependence between each data
set using Pearson and pairwise Spearman rank correlation in the
R environment (R Core Team, 2013).
Functional Annotation and Metagenomic
Profiling of Fecal DNA
A total of 12 DNA stool samples were sequenced using the
Illumina HiSeq next-generation sequencing platform carried
out at Genoma Mayor (Universidad Mayor, Chile) with an
output of 2 × 100 pb and 20 × 106 paired-end reads per
sample. The raw data produced from DNA sequencing in
this study were stored at the ENA-EMBL database under the
accession number PRJEB29060. To evaluate the taxa abundance
and metagenomic composition, all metagenomic raw sequences
were analyzed in parallel using the Microbiome Helper v2.3
environment following the metagenomics SOP v2 tutorial.
This pipeline allowed the calculation of microbiota abundance
using functions from MetaPhlAn2 (Truong et al., 2015) and
functional profile using HUMAnN2 (Abubucker et al., 2012).
DNA sequence quality control was performed using KneadData
(McIver et al., 2018), in which low quality sequences were
first removed by Trimmomatic (Bolger et al., 2014), followed
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TABLE 1 | Description of studies used in this work.
Study Country Methodology N◦ lean subjects N◦ obese subjects DOI
Medina et al., 2017 Chile 16S rDNA Amplicon 0 19 doi: 10.7717/peerj.3443
Thomson et al., 2019 Chile 16S rDNA Amplicon 28 0 doi: 10.1017/S0007114519001570
Yasir et al., 2015 France 16S rDNA Amplicon 12 16 doi: 10.1038/nutd.2015.3
Yasir et al., 2015 Saudi Arabia 16S rDNA Amplicon 9 9 doi: 10.1038/ismej.2017.71
Ilhan et al., 2017 United States 16S rDNA Amplicon 10 15 doi: 10.1038/ismej.2017.71
Medina, this study Chile Shotgun metagenomics 0 6 This study
Palleja et al., 2016 Denmark Shotgun metagenomics 0 13 doi: 10.1186/s13073-016-0312-1
Tremaroli et al., 2015 Italy Shotgun metagenomics 0 7 doi: 10.1016/j.cmet.2015.07.009
by the application of Bowtie2 to screen out the contaminant
DNA sequences mainly from human and viruses (Langmead
and Salzberg, 2012). Both programs were run simultaneously for
all samples using the GNU Parallel tool to repeat concatenate
the entire process for each data set (First and Job, 2011).
The paired-end files were merged using the script provided
by the Microbiome Helper pipeline and then taxonomic and
functional profiling were performed using MetaPhlAn2 and
HUMAnN2, respectively. Gene family and pathway abundances
were normalized for each sample and represented as a percentage.
The resulting tables were exported to the R environment (R Core
Team, 2013) for statistical analysis and figure representation.
Metadata sets used for DNA shotgun sequencing to obtain
stratified and unstratified metagenomic profiles are listed in
Supplementary Table S3.
Data Comparison and Statistical
Analysis
Statistical analyses were conducted using the R environment
(R Core Team, 2013) version 3.4.4 (2018-03-15). Before
calculations between countries, data sets were scaled
proportionally, and using the R package preprocessCore
(Bolstad, 2019), quantile normalization was performed to reduce
batch effects between data belonging to different sources as was
previously used for genome-wide analyses (Sun et al., 2011; Guo
et al., 2014; Fei et al., 2018). For differential analysis of group
variance between lean and obese microbiota abundance, we used
Canonical Correspondence Analysis (CCA, a.k.a. constrained
correspondence analysis) and Adonis tests, in which both were
calculated using the R package vegan (Oksanen et al., 2018). The
Adonis test was used for permutational multivariate analysis of
variance using distance matrices, in which samples were fitted
to linear models to calculate the whole compositional variability
taking into account different sources of variation as well as
the interactions between them. Spearman’s rank correlation
analyses were used to assess taxa abundance or functional
abundance associations between the samples groups. To analyze
differences in group means between lean and obese microbiota
abundance, we applied Wilcoxon sum rank test with FDR
adjustment utilizing the Benjamini Hochberg (BH) method. This
was performed using the R command p.adjust(), in which we
considered tests with FDR < 0.05 to be significant. In order to
identify differentially enriched biomarkers among the compared
groups, we applied the LEfSe analytic method using the online
interface Galaxy1 (Segata et al., 2011). Statistical differences
between the KEGG Orthology abundances were calculated
using the unpaired t-test and adjusted by BH FDR as described
above. –log10 FDR was plotted against log2 ratio of each country
in respect to Chile and represented using the R package LSD Lots
of Superior Depictions (Schwalb et al., 2011).
RESULTS
Gut Microbial Diversity Is Specific to
Geographic Locations
The composition and function of the human gut microbiota
represent one of most important factors involved in obesity
and its treatment (Ley et al., 2006; Tremaroli and Backhed,
2012; Karlsson et al., 2013; Le Chatelier et al., 2013; Damms-
Machado et al., 2015; Medina et al., 2017). It has been previously
established that the human gut microbiota displays pronounced
differences between individuals residing in distinct geographic
locations (Yatsunenko et al., 2012; Fujio-Vejar et al., 2017;
Gupta et al., 2017). It is therefore of great interest to compare
the microbial diversity of obese individuals from different
geographical locations around the world. In this line of research,
this study compared the gut microbial diversity of obese and
lean subjects from Chile (Medina et al., 2017; Thomson et al.,
2019) with data published by other studies in different regions
around the world, namely United States (Ilhan et al., 2017),
France and Saudi Arabia (Yasir et al., 2015), described in
Table 1. Taxonomic microbiota abundance were collected by
sequencing the 16S rDNA hypervariable regions V3–V4 or V4–
V5 using the Illumina MiSeq platform (Supplementary Table
S1), and raw data was processed as described in materials
and methods. Taxonomic abundance comparisons at the genus
level from the data obtained showed significant diversity in
microbiota composition in lean people as previously reported
(Yatsunenko et al., 2012; Nishijima et al., 2016; Fujio-Vejar
et al., 2017; Gupta et al., 2017), but also is country specific
in gut microbiota of obese subjects. Specifically, data variance
analysis using CCA and Adonis tests showed significant
differences (p-value < 0.05) in the gut microbiota composition
between Chile, United States, France, and Saudi Arabia,
in which the lean and obese microbiota were clustered
1http://huttenhower.sph.harvard.edu
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by country (Figures 1A,B). Utilizing a different approach,
pairwise Spearman rank correlation, we further demonstrated
that the taxonomic abundance correlation of obese gut
microbiota differed between countries (Supplementary Figure
S1A). Nevertheless, although obese microbiota composition
is clustered by country, there is significant inter-individual
variability between subjects, indicated by high dispersion
patterns observed in data variance analyses (Figure 1). In
this regard, although some proximity is observed between
France and Saudi Arabia microbiota, CCA and Adonis test
variance analyses between the two countries shows a significant
statistical difference (Supplementary Figure S1B). In all, these
comparisons indicate that the microbiota compositions of obese
patients and lean subjects were specific to each analyzed
geographic location and displayed significant differences between
countries. Comparing taxonomic abundance of obese individuals
with their lean counterparts from the same country we
observed significant differences by multivariate variance analyses
for Chile, France, and Saudi Arabia (CCA p-value < 0.05);
however, no statistically significant differences were observed
for United States (Supplementary Figure S2). Wilcoxon sum-
rank tests showed significant differences (FDR < 0.05) between
lean and obese microbiota in Chile and France data sets,
but not in United States and Saudi Arabia. Interestingly,
although CCA showed clustering by country in both cases,
France and Chile shared some genus changes between lean
and obese microbiota (Megasphaera, Veillonella, Adlercreutzia
and Lachnospira) (Supplementary Table S2). In addition,
heatmap clustering by complete linkage method and the
stacked bar plot of taxonomic abundances showed differential
patterns not only between obese and lean subjects, but also
between countries, which again highlights our observation
that taxonomic microbial distribution is specific to each
country (Figure 2).
Next, using the PICRUSt tool (Langille et al., 2013) designed
to infer the functional patterns from taxonomic profile, we
compared predicted KEGG Orthology (KO) enrichment of obese
subjects from United States, France, and Saudi Arabia with
the KO obtained from the obese Chilean data as reference
in order to identify potential functional differences. Here, we
observed significant differences (FDR < 0.05) in enriched
pathways for all the countries studied with respect to Chile
(Figure 3). Downregulated pathways in Saudi Arabia displayed
an enrichment in translation and energy metabolism, whereas
the United States and France showed a downregulation in
membrane transport. For upregulated pathways, United States
showed a specific enrichment in cellular processing and
signaling and amino acid metabolism, whereas France and
Saudi Arabia were found to enrich in pathways involving
membrane transport (Supplementary Figure S3). In summary,
the differences observed by functional prediction suggested that
the human gut metagenome of obese subjects, like their healthy
counterparts (Yatsunenko et al., 2012), may differ according to
the geographical location.
Metagenomic Variations Across Regional
Location in the Context of Obesity
Our initial analysis utilizing 16S rDNA amplicon sequencing
showed marked differences between the compositions of the gut
microbiota of obese subjects from different countries, therefore,
to further validate our initial observation, we analyzed stool
samples of 6 Chilean pre-treatment obese patients obtained
from a previous study (Medina et al., 2017) by shotgun DNA
FIGURE 1 | Taxonomic abundance comparison at genus level from 16S rDNA sequencing. Constrained Correspondence Analysis (CCA) and Adonis test were
performed to assess the variance in microbiota profiles at the genus level in lean (A) and obese (B) subjects. Vectors represent quantitative explanatory variables
with confidence circles depicted for each country. Corresponding p-values are shown for each analysis and p-value < 0.05 was considered statistically significant. x-
and y-axis show CCA1 and CCA2 components, respectively. Green, blue, brown and red points indicate individuals from France, United States, Saudi Arabia, and
Chile, respectively.
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FIGURE 2 | Heatmap clustering and stacked bar plot of taxonomic abundances of lean and obese subjects at genus level. (A) Taxonomy abundance at genus level
between obese and lean subjects were clustered using complete linkage method. Values indicate abundance of microbiota at the genus level. (B) Average taxonomy
abundance at genus level were represented as stacked bar plot to of lean and obese subject of each country. x-axis depicts percentage of abundance of each
taxonomy. Dark and light blue represent obese and lean subjects, respectively. Red, blue, green, and brown represent individuals from Chile, United States, France,
and Saudi Arabia, respectively.
FIGURE 3 | Volcano plot of KEGG Orthology abundances obtained from metagenomic simulation. Fold change of United States (A), France (B), and Saudi Arabia
(C) of KO abundance with regard to Chile are plotted against –log10 of FDR. Dotted lines in the x-axis denotes a two-fold change, while dotted lines in the y-axis
delimit a FDR value of 0.05.
sequencing in order to dissect the contribution of metabolic
functional changes and microbiota compositions. Additionally,
we compared the results obtained from the Chilean cohort with
similar studies carried out from patients in Italy (Tremaroli et al.,
2015) and Denmark (Palleja et al., 2016), described in Table 1.
All raw data were analyzed using the Metagenomic SOAP v2
from Microbiome Helper (Comeau et al., 2017) as described
in “Materials and Methods.” First, we compared the functional
composition of obese subjects from Chile (n = 6), Italy (n = 7) and
Denmark (n = 7) before any medical intervention utilizing CCA,
Adonis tests and pairwise Spearman rank correlation. Initially,
we performed an unstratified analysis, which corresponds to
the analysis of metabolic pathway enrichment without taking
into account microbial composition, and observed no statistically
significant differences between the three countries using CCA
analysis and Adonis tests (p-value > 0.05), in which the variance
plot displayed little dispersion between the samples from different
countries (Figure 4A). Furthermore, the pairwise Spearman
rank correlation showed overall good correlation between the
samples of all datasets (Figure 4B). Hence, in contrast to
PICRUSt prediction, these results showed that the overall
microbial functionality had no differences between obese subjects
belonging to different world regions. Subsequently, we performed
a stratified data analysis, a type of analysis that distinguishes
the functional contribution of each bacterial species to the
overall metabolic pathways. Interestingly, stratified data, unlike
Frontiers in Microbiology | www.frontiersin.org 6 October 2019 | Volume 10 | Article 2346
fmicb-10-02346 October 17, 2019 Time: 14:16 # 7
Medina et al. Cross-Regional View of Obesity Gut Microbiota
unstratified analysis, showed significant dispersion between the
countries (Figure 4C), and no correlation between datasets
was observed (Figure 4D), indicating that individual microbial
metagenomic contribution to overall functional pathways is
different between countries, in agreement with functional
inferences obtained by PICRUSt (Figure 3). Also, we use
the Spearman rank correlation values obtained to compare
statistically into-countries and cross-country associations in
both unstratified and stratified data, finding no statistical
differences between Spearman values (p-value FDR adjusted
of 0.75 and 1, respectively). Utilizing linear discriminant
analysis (LDA) to quantify phylogenetic and functional diversity,
pathways over 1.5 LDA score were found to be differentially
enriched between countries in both stratified and unstratified
approaches (Figure 5). In addition, we validated the PICRUSt
functional prediction comparing KEGG Orthology obtained with
HUMAnN2 output from metagenomic data using Pearson and
pairwise Spearman rank Correlation, with both showing linear
dependence between 3590 common KEGG Orthology families
(Supplementary Figure S4 and Supplementary Table S5), which
proved the relationship between in silico predictions and our
biological findings as was previously demonstrated by PICRUSt
authors (Langille et al., 2013). Altogether, these results suggested
that microbial contribution to functional pathways was country-
specific, indicating that there was redundancy in the functions
of these distinct microbial species found in obese subjects from
different countries, in which different microbiota components
contribute to obtain similar metabolic outcomes.
Furthermore, microbial taxonomy abundance data obtained
from shotgun DNA sequencing showed that Chilean microbiota
composition from obese subjects was different compared to
Italian and Danish cohorts (Tremaroli et al., 2015; Palleja
et al., 2016). CCA analysis and Adonis tests showed significant
differences between the microbiota of analyzed subjects at species
level (Supplementary Figure S5A), which strengthens our
previous observations obtained from the 16S rDNA sequencing
taxonomic comparison at genus level (Figure 1B). In addition,
LDA analysis showed differences in species abundance between
the three microbial datasets species with and LDA scores higher
than 2, reinforcing the observation that the microbiota under
dysbiosis has different compositions specific to each geographical
location (Supplementary Figure S5B).
Gut Microbiota Functionality Changes
Following Bariatric Surgery in Chilean
Subjects
Several studies have shown that the regulation of energy and fat
storage is influenced by intestinal microbes, and this composition
may contribute to obesity (Qin et al., 2012; Karlsson et al., 2013).
In this regard, it has been reported that human gut microbiota
composition varies between obese patients who underwent
different types of surgical intervention (Zhang et al., 2009; Furet
et al., 2010; Schloss, 2016; Ilhan et al., 2017; Medina et al., 2017;
Murphy et al., 2017). Moreover, several of these studies describe
functional changes after treatment and its prevalence across time
(Tremaroli et al., 2015; Palleja et al., 2016). More specifically, they
report an increase in Proteobacteria abundance and facultative
anaerobes, such as E. coli, and an enrichment in microbial
pathways involving aerobic respiration, glutathione and gamma-
aminobutyric acid metabolism. Similarly, in a previous study
from our laboratory using Chilean obese patients, we observed
significant changes in the human gut microbiota, and these
changes were specific to the type of surgery performed (Medina
et al., 2017). Here, utilizing the same cohort, we performed
shotgun DNA sequencing of stool samples before and after
surgical intervention in order to analyze changes in taxonomic
composition (Medina et al., 2017). Although no statistical testing
was performed due to insufficient cohort number (n = 2
for each group), our results suggested that the two kinds of
bariatric surgery mediated different rearrangements of functional
pathways. We found stratified and unstratified functional
changes of several folds, 6 months following either Roux-en-Y
gastric bypass (RYGB) or sleeve gastrectomy (SG) interventions
(Figure 6). More specifically, unstratified functional changes
were more pronounced in RYGB–treated patients compared to
SG-treated patients, represented by higher data variance with an
increase in log2 fold change (Figures 6B,D). Functional changes
in unstratified RYGB data suggested an increase in pathways
related with acetyl-CoA biosynthesis, trehalose degradation,
GABA shunt and phospholipid remodeling. Contrastingly,
changes observed in SG intervention included an increase in
metabolic pathways such as fatty acid β-oxidation, TCA cycle
and acetyl-CoA biosynthesis (Supplementary Table S4). Top
stratified functional changes after RYGB were mainly driven
by A. muciniphila, E. coli, Bacteroides vulgatus, Eubacterium
siraeum and Streptococcus salivarius, while in SG functional
changes were driven by Bacteroides cellulosilyticus, S. salivarius,
Eubacterium eligens, Lactococcus lactis, Alistipes finegoldii, E. coli
and A. muciniphila (Supplementary Table S4). Altogether, these
results suggested that bariatric surgery in Chilean patients also
caused functional rearrangement in microbiota, in concordance
to previous metagenomic studies (Graessler et al., 2013;
Tremaroli et al., 2015; Palleja et al., 2016), and these changes
appeared to be specific to the surgery performed.
DISCUSSION
Obesity is a world-wide health problem whose global prevalence
has increased at an accelerated rate since 1980 (Stevens et al.,
2012). It has been previously described that the composition
and functionality of human gut microbiota plays a crucial
role in mediating both disease and recovery following medical
intervention (Turnbaugh et al., 2006; Tremaroli and Backhed,
2012; Karlsson et al., 2013; Le Chatelier et al., 2013; Damms-
Machado et al., 2015). This study compared the gut microbiota
compositions of obese subjects from Chile with previously
published data from the United States, France, and Saudi Arabia
using 16S rDNA Illuminia MiSeq, as well as from Italy and
Denmark using Illumina HiSeq shotgun metagenomics, and
found that the microbiota composition differs significantly
between obese and lean subjects from these different countries,
showing country-specific clustering. It has previously been
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FIGURE 4 | Stratified and unstratified functional profiles of obese gut microbiota from three different countries. Unstratified (A,B) and stratified (C,D) analyses of
obese gut microbiota abundance for Chile (red), Italy (blue) and Denmark (green). Scatterplots (A,C) represent CCA and Adonis test analysis, and heatmap (B,D)
represent pairwise Spearman rank correlation of functional microbial abundance between countries.
described that a number of factors can modulate the composition
of intestinal microbiota, one of which is geographic origin
(reviewed by Rojo et al., 2017). A previous study compared
the microbiota composition of a group of healthy subjects
from France with Saudi Arabia by 16S rDNA sequencing and
suggested that the dietary habits of different regions or countries
can generate changes in intestinal microbiota (Yasir et al.,
2015). This idea was reinforced by other studies suggesting that
different types of diets directly change microbiota composition
(Wu et al., 2011; Fava et al., 2013). In fact, mice subjected to
obesogenic diets displayed significant functional and taxonomic
modifications in their gut microbiota (Tran et al., 2019). Other
studies show that genetics play a secondary role compared to
environmental factors (Gupta et al., 2017; Jones et al., 2018;
Rothschild et al., 2018). However, twin studies revealed more
highly correlated microbiota compositions between monozygotic
twins than dizygotic twins (Goodrich et al., 2014). Given
subjects belonging to close location have less genetic variance
than subjects from distant regions, this may also contribute
to the differences in microbiota composition observed between
geographical origins.
Our work attempted to indicate the need for the global study
of human microbiota for a proper assessment of the microbial
contribution in respect to geographic distribution. In this
context, we compared the taxonomic gut microbiota abundance
of lean and obese at genus level using multivariate variance
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FIGURE 5 | Linear discriminant analysis (LDA) effect size (LEfSe) of metabolic pathways. Unstratified (A) and stratified (B) functional enrichment analyses from
microbiome of obese subjects belonging to Chile (red, n = 6), Denmark (green, n = 7) and Italy (blue, n = 7). Pathways with LDA scores higher than 1.5 (A) or 2 (B)
are shown. For stratified functional enrichment (B), unmapped/unintegrated reads are denoted as the bacterial taxa in which the pathways belong to.
FIGURE 6 | MA Plots for stratified and unstratified functional changes after bariatric surgery in Chilean patients. (A,B) Gastric bypass and (C,D) sleeve gastrectomy
stratified (A,C) and unstratified (B,D) functional changes 6 months post-surgery. Values are expressed as mean (x-axis) and fold change (y-axis), and represented as
log2 values. Dotted lines denote a two-fold change.
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analysis and non-parametric mean comparison. Although, using
Wilcoxon rank test, we found different statistical changes
in France and Chile gut microbiota, this was, however, not
the case for United States and Saudi Arabia. Our results
suggest a country-specific signature for both lean and obese
microbiota. Nevertheless, we cannot discard the possibility
that our observations may be influenced by technical and
methodological factors. First, it is known that non-parametric
tests have less chance of detecting a true effect where one
exists (Whitley and Ball, 2002). Hence, utilizing a different
statistical approach to analyze differences in variance (CAA
and Adonis test) between lean and obese subjects in France,
Chile, and Saudi Arabia, the subsequent results support the
notion that obese versus lean microbiota is different between
countries. Second, we cannot discard that this observation may
be relatively influenced by the methodology differences between
studies and also may be confounded by large interpersonal
variation. A meta-analysis of the association between differences
in the microbiome and obesity status made between 10 published
studies found that is difficult to classify a subject as obese by
its microbiota composition, suggesting the possibility that each
individual has their own bacterial signatures (Sze and Schloss,
2016). Another meta-analysis that compared lean and obese
subject from five published studies also found that signatures
of obesity were not consistent between studies, as just one of
the 5 studies analyzed showed diversity differences between
lean and obese subject (Walters et al., 2014). Nevertheless,
the authors declared that it was possible to assess differences
between lean and obese subjects when they changed the
method to identify OTUs (from “close reference” to “pick de
novo”) or used supervised learning tools to categorize subjects
according to lean and obese states with considerable accuracy
(Walters et al., 2014). Altogether, these observations suggest that
geographical differences between lean and obese subjects requires
additional validation using an international cohort that not only
takes into account confounding factors but maintain the same
experimental design.
Our study performed a functional inference analysis based
on the data obtained by 16S rDNA sequencing and observed
significant differences in KEGG Orthology enrichment in
samples obtained from France, United States, and Saudi Arabia
compared to Chile. These results suggested the microbial
differences observed were associated with changes in functional
pathways, however, this kind of analysis was unable to
differentiate the microbial contribution of each microorganism
species to the identified functional pathways. Therefore, a
more detailed comparison of metagenomic DNA sequencing
data was used, which was obtained using the HiSeq platform
to analyze stool samples of obese patients from Chile, Italy
and Denmark. First, we performed an unstratified analysis,
a type of metabolic pathway enrichment analysis without
taking into account microbial contribution, and revealed that
the functionality in obesity context did not show statistical
differences (in both CCA and Adonis testing) between patients
from Chile, Italy and Denmark, suggesting that gut microbiota
metabolic pathways do not change according to geographic
origin. Conversely, using a stratified approach that could
identify specific microbial composition and their individual
contribution to metabolic pathways, significant differences
between countries were identified, in agreement with our
initial PICRUSt metabolic inference, because both methods
takes in account taxonomic composition to assess metabolic
pathways abundance. Altogether, our observations indicate while
overall metabolic functions do not change, microbial functional
contribution to obesity are specific to each country.
Although the lack of differences observed in metagenomic
unstratified analysis may be due to small cohort numbers, our
comparisons suggest that the gut microbiota of obese patients
from different countries have functional convergence, where the
same essential metabolic functions are carried out by related
and unrelated bacterial species. Nevertheless, it is not surprising
that bacterial compositions of obese individuals differ between
counties due to both genetic and environmental factors, as
previously described by others (reviewed by Gupta et al., 2017),
however, our observations relating to convergent metabolic
functions provide new insights into how the gut microbiota
shape common disease phenotypes. The concept of intestinal
functional redundancy has been previously explored, in which
taxonomic diversity appears to be irrelevant for the inference
of functional traits (reviewed by Moya and Ferrer, 2016; Rojo
et al., 2017). One such example was demonstrated by the Human
Microbiome Project Consortium (Huttenhower et al., 2012),
where the authors observed the microbial metabolism to remain
constant across individuals over time despite high variability in
composition. One possible explanation of microbial functional
redundancy can be due to the evolutionary convergence of
unrelated taxa, in which variable combinations of species from
different phyla can at least partially fulfill the metabolic functions
of another, resulting in different species of bacteria behaving
similarly (Moya and Ferrer, 2016; Rojo et al., 2017).
Bariatric surgeries have become a frequent choice of treatment
for obesity patients over the last years, being SG the most frequent
procedure in the world (Angrisani et al., 2017; reviewed by
ASMBS, 2018). Several studies have shown that the intestinal
microbiota composition changes following surgical intervention
and these changes vary between patients who have undergone
different kind of surgical intervention such as RYGB, SG and
laparoscopic adjustable gastric banding (LAGB) (Tremaroli et al.,
2015; Palleja et al., 2016; Ilhan et al., 2017; Medina et al., 2017).
One of the limitations of our metagenomic study after bariatric
surgery is our small cohort number (n = 2 for each group),
and therefore, further studies with larger cohort are required
to confirm that different treatments mediate differentially
metagenomic rearrangements. However, this study suggest that
the microbial functionality of patients changed 6 months
following surgical treatment. In agreement with previous studies,
it also observed specificity in the changes regarding to the type
of surgery performed, where functional changes were mainly
mediated by A. muciniphila, E. coli, B. vulgatus, E. siraeum and
S. salivarius after RYGB, and by B. cellulosilyticus, S. salivarius,
E. eligens, L. lactis, A. finegoldii, E. coli and A. muciniphila species
after SG. Although it is impossible to determine from this study
whether the microbiota composition changes were a consequence
of dietary changes or weight modification, our results not only
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hint at a microbiota signature for different bariatric surgeries,
but also suggest the need for further microbiota meta-
analyses at world-wide levels to study metabolic disorders
such as obesity.
A common key factor in obesity is the low abundance of
A. muciniphila (Schneeberger et al., 2015; Palleja et al., 2016;
Medina et al., 2017; Seck et al., 2018), a mucin-degrading
bacterium that resides in the human gut mucus layer and whose
abundance in healthy subjects represents 3–5% of the residential
microbial community (Derrien et al., 2004). Interestingly, it
has been shown that A. muciniphila prevents inflammation and
adipose tissue alterations in mice (Schneeberger et al., 2015).
The administration of A. muciniphila grown under mucin-
depleted conditions is effective in reducing obesity and improve
intestinal barrier integrity in obese mice (Shin et al., 2019),
controls fat mass storage and glucose homeostasis in obese
and type 2 diabetic mice (Everard et al., 2013), and it has
been previously described that bariatric surgery improves its
abundance (Damms-Machado et al., 2015; Tremaroli et al., 2015;
Palleja et al., 2016; Medina et al., 2017). Furthermore, overweight
and obese individuals with higher A. muciniphila abundance
is associated with a healthier metabolic status compared with
lower abundance (Dao et al., 2016). Therefore, the enrichment
of A. muciniphila provides a possible therapy in the treatment
of obesity, and this possibility has been explored in a recent
study (Sheng et al., 2018). Here, we identified A. muciniphila
as one of the bacteria that drove the changes in metabolic
pathways after surgical intervention of Chilean obese patients,
an important observation considering that gut microbiota of
healthy Chilean subjects has high abundance of Verrucomicrobia
bacteria, including A. muciniphila (Fujio-Vejar et al., 2017).
Further studies to understand the underlying mechanisms
involving A. muciniphila as a target of bacto-therapy to treat
obesity are required.
Our results, together with previously published studies,
highlight the need to consider region-specific analysis
of the gut microbiota in order to fully understand the
bacterial basis for the development of such diseases as
obesity and the response to surgical and non-surgical
treatment, opening to the possibility that probiotic
development to treat different kinds of dysbiosis should be
country-specific.
CONCLUSION
This study identified significant differences in the human gut
microbiota of obese patients from around the world, and found
that functional dissimilarities were mediated by differences
in taxonomic microbiota composition, which were region-
specific, rather than alterations in metabolic pathways. This
indicates the presence of functional metabolic redundancy
between the microbiota of obese patients despite the bacterial
differences and geographic origin. Furthermore, functional
changes in gut microbiota following bariatric surgery were
observed to be specific to the type of treatment received,
providing new insights into the role of the gut microbiome in
treatment strategies.
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